Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02378181 · ClinicalTrials.gov registry record · NA
Testing the Effectiveness of a Graphic Novel Health Education Curriculum for Patients With Addiction
A NA study of Drug Use and Alcohol Use, sponsored by Treatment Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
- 2
- Study locations
NCT02378181: Completed NA study of Drug Use and Alcohol Use, sponsored by Treatment Research Institute.
NCT02378181 is a NA study of Drug Use and Alcohol Use that has completed, run by Treatment Research Institute. The registered enrollment target is 49 participants, below the 222-participant average among 25 other Drug Use trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02378181, a NA study of Drug Use and Alcohol Use, has completed, sponsored by Treatment Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study deploys a strategy to develop and evaluate a training-efficient, multimedia patient-centered Health Education Toolkit to promote shared decision making between counselors and patients. An existing evidence-based toolkit intervention will be adapted and redesigned by a patient and provider team into an engaging, narrative graphic novel curriculum useful in group and individual counseling. The proven behavioral interventions will be augmented with health education material focused on medication assisted treatment (MAT). We will assess feasibility and acceptability, and pilot test whether exposure to the Toolkit (TK) can shared decision making conversations, reduce substance use, and increase engagement with MAT.
Primary Outcome
Shared decision making score, as measured by the Shared Decision Making Questionnaire (SDM-Q) which uses a 1-6 point scale with higher numbers indicating greater shared decision-making. Results are presented for one research site only because of counselor randomization issues at the second site (i.e., the randomization was extremely unbalanced with 7 TAU counselors and 1 TK counselor).
Conditions Studied
Interventions
- BEHAVIORAL Treatment-as-usual
- BEHAVIORAL Health Education Toolkit
Study Locations (2)
Pennsylvania
- Wedge Medical Center - Philadelphia
- Kirkbride Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2016-08-16 |
| Est. Completion | 2017-04-15 |
| Phase | NA |
What the finished NCT02378181 record still lists
NCT02378181 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 222-participant average among 25 other Drug Use trials with a reported enrollment target (78% lower).
The record links to 2 conditions, with Drug Use appearing as the primary indexed condition, and to 2 interventions - of which Treatment-as-usual is the first listed.
NCT02378181 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02378181 about?
NCT02378181 is a clinical study titled "Testing the Effectiveness of a Graphic Novel Health Education Curriculum for Patients With Addiction". This study deploys a strategy to develop and evaluate a training-efficient, multimedia patient-centered Health Education Toolkit to promote shared decision making between counselors and patients. An existing evidence-based toolkit intervention will be adapted and redesigned by a patient and provider...
What is the current status of trial NCT02378181?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2016-08-16. Estimated completion is 2017-04-15.
What conditions does trial NCT02378181 study?
This clinical trial studies the following conditions: Drug Use, Alcohol Use.
What interventions are being tested in trial NCT02378181?
The interventions under investigation include: Treatment-as-usual (BEHAVIORAL), Health Education Toolkit (BEHAVIORAL).
Who is sponsoring clinical trial NCT02378181?
This trial is sponsored by Treatment Research Institute, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02378181 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Drug Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02378181's enrollment target sits among peer trials
49 20th of 25 higher than 6 of 25 other Drug Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Drug Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Families With Pride ("Familias Con Orgullo").
RECRUITING · NA
-
Lakota Family Acceptance Project
RECRUITING · NA
-
Mental Health in Primary Care
RECRUITING · NA
-
Developing a Positive Approach to Substance Use Prevention in North American Indian Adolescents
RECRUITING · NA
-
Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation
RECRUITING · NA
-
Harm Reduction Services
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI